Cryoport, Inc. (CYRX) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Thu, Aug 6, 2026after close 37 8-K
Q1 FY2026Mon, May 4, 2026after close 34 8-K
Q4 FY2025Tue, Mar 3, 2026after close 62 8-K
Q3 FY2025Tue, Nov 4, 2025after close 35 8-K
Q2 FY2025Tue, Aug 5, 2025after close 36 8-K
Q1 FY2025Wed, May 7, 2025after close 37 8-K
Q4 FY2024Tue, Mar 4, 2025after close 63 8-K

What they guided beta

Q3 FY2026 "full-year 2026 revenue guidance to $197 million - $199 million" exhibit
Read from the sentence: revenue $197 million to $199 million, FY2026
Q3 FY2026 "As a result, we are increasing our full-year 2026 revenue guidance to a range of $197 million to $199 million,” concluded Mr." exhibit
Read from the sentence: revenue $197 million to $199 million, FY2026
Q3 FY2026 "Two of Cryoport’s customers filed Biologics License Applications (BLA) with the FDA in the third quarter and we anticipate another five possible BLA or Marketing Authorization Applications (MAA) in 2026." exhibit
Q3 FY2026 "Cryoport also anticipates two possible additional new therapy approvals (both of which have received Prescription Drug User Fee Act (PDUFA) dates from the FDA for Q4 2026), and one possible additional supplemental approval for geographic expansion from our customer base this year." exhibit
Q3 FY2026 "Revenue Guidance for Full-Year 2026" exhibit
Q2 FY2026 "For the balance of 2026, we anticipate another 11 possible BLA/MAA applications, five possible additional new therapy approvals, and one possible additional approval for label/geographic expansion from our customer base." exhibit
Q2 FY2026 "· Advanced toward the planned launch of BioServices operations at our Global Supply Chain Center in Paris, France, expected in Q4 2026." exhibit
Q2 FY2026 "· Continued progress toward the launch of our state-of-the-art Global Supply Chain Center in Santa Ana, California, expected in Q4 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CYRX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CYRX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

CYRX earnings date badge

HTML

<a href="https://veritasdata.dev/company/CYRX/"><img src="https://veritasdata.dev/embed/CYRX.svg" alt="CYRX earnings date" width="240" height="56"></a>

Markdown

[![CYRX earnings date](https://veritasdata.dev/embed/CYRX.svg)](https://veritasdata.dev/company/CYRX/)

Script

<script async src="https://veritasdata.dev/embed/CYRX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CYRX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.